Medikit Co.,Ltd. (TYO:7749)
2,662.00
+86.00 (3.34%)
Mar 10, 2025, 3:30 PM JST
Medikit Revenue
Medikit had revenue of 6.06B JPY in the quarter ending December 31, 2024, with 0.70% growth. This brings the company's revenue in the last twelve months to 22.33B, up 1.42% year-over-year. In the fiscal year ending March 31, 2024, Medikit had annual revenue of 21.85B with 1.12% growth.
Revenue (ttm)
22.33B
Revenue Growth
+1.42%
P/S Ratio
1.79
Revenue / Employee
23.12M
Employees
966
Market Cap
39.54B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 21.85B | 243.00M | 1.12% |
Mar 31, 2023 | 21.61B | 1.48B | 7.34% |
Mar 31, 2022 | 20.13B | 818.00M | 4.24% |
Mar 31, 2021 | 19.31B | -581.00M | -2.92% |
Mar 31, 2020 | 19.89B | 1.39B | 7.52% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 837.44B |
Terumo | 1,011.15B |
Otsuka Holdings | 2,329.86B |
Astellas Pharma | 1,867.63B |
Olympus | 993.33B |